‘Profound’ financial, workforce challenges persist for senior living providers as 2024 begins
By
Lois A. Bowers
Jan 02, 2024
Senior living operators will continue to face inflationary pressures and capital market challenges in 2024, but some effects may lessen before the year is out, according to senior living industry experts....
Long COVID incidence declined over course of pandemic
Jul 23, 2024
The authors say, however, that the risk remained substantial, even among vaccinated persons during the omicron era.
Severity of COVID-19 reinfection linked to severity of initial infection
Jul 18, 2024
Individuals who experienced severe initial and first reinfection were older in age and had a higher mortality risk.
Postexposure prophylaxis with nirmatrelvir-ritonavir does not cut COVID-19 Infection
Jul 18, 2024
No significant reduction was seen in the risk for symptomatic SARS-CoV-2 infection with postexposure prophylaxis for five or 10 days.
Hospital-onset SARS-CoV-2 infection during omicron linked to morbidity
Jul 15, 2024
Hospital-onset SARS-CoV-2 remained associated with increased morbidity and mortality during the omicron era.
Severe SARS-CoV-2 appears to infect coronary vessels
Oct 05, 2023
SARS-CoV-2 targets plaque macrophages, and its entry is increased in cholesterol-loaded primary macrophages.
Dementia rate decline accelerates during COVID-19 pandemic
By
Eliza Mattson
Jul 23, 2024
Before the COVID-19 pandemic, the rate of older adults living with dementia was decreasing. The pandemic accelerated that decline, however, due to an increase in deaths among older adults living with dementia,...
Pandemic control practices cut healthcare-acquired infections
Oct 18, 2023
A reduction also was seen in nosocomial respiratory viral infections.
Following drop after COVID-19 onset, inappropriate antibiotic prescribing is up
May 01, 2024
An initial decrease was seen in proportion with inappropriate prescription, followed by a subsequent increase.
Long-term smell, but not taste, deficits seen after COVID-19
May 01, 2024
The deficits appear to be the greatest for individuals with the original untyped and alpha variant infections.